It has been shown that PBNK cells may lose their cytotoxic ability by acquiring HLA-G, a non-classical MHC class I molecule, from transfected melanoma cell lines through trogocytosis, while the cytotoxic ability can be reversed once the phagocytosed HLA-G is degraded or turned over. Here, HLA-G is linked to melanoma.